Loading…
ClearPoint Neuro, Inc. is projected to rise to $30.39 by 2027, a +74% move from its current price of $17.50. CLPT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $16.79 | $17.51 | $18.25 | +0.03% |
| Jul 14 | $16.51 | $17.51 | $18.57 | +0.07% |
| Jul 15 | $16.30 | $17.52 | $18.83 | +0.10% |
| Jul 16 | $16.12 | $17.52 | $19.05 | +0.13% |
| Jul 17 | $15.97 | $17.53 | $19.24 | +0.17% |
| Jul 18 | $15.83 | $17.53 | $19.42 | +0.20% |
| Jul 19 | $15.71 | $17.54 | $19.58 | +0.23% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.71 | $17.54 | $19.58 | +0.23% |
| Week 2 | $15.04 | $17.58 | $20.55 | +0.47% |
| Week 3 | $14.56 | $17.62 | $21.33 | +0.70% |
| Week 4 | $14.17 | $17.66 | $22.02 | +0.93% |
| Week 5 | $13.84 | $17.70 | $22.65 | +1.17% |
| Week 6 | $13.55 | $17.75 | $23.24 | +1.41% |
| Week 7 | $13.29 | $17.79 | $23.81 | +1.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ClearPoint Neuro, Inc. is a healthcare company focused on developing and commercializing platforms for performing minimally invasive brain surgery in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula.
It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC.
The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
ClearPoint Neuro, Inc. (CLPT) is a healthcare stock trading at $18.53 with a market cap of $555.71M and a rank of 2965. It operates in the healthcare sector, focusing on medical device platforms for brain surgery and related services.
The stock’s price outlook is largely exposed to a multi-year forecast showing upside from 2026 onward, with current 2026 average price matching the present level and substantial growth expected in later years. The forecast table provides year-by-year averages and ROIs through 2050, illustrating a long-run appreciation path despite near-term uncertainty.
A major floor 50.5% below — a decisive break under it would weaken the trend.
The nearest floor, 30.1% below — buyers have tended to step in here.
The nearest ceiling, 11.0% above — a clean break opens room to run.
A major ceiling 34.7% above — clearing it would confirm fresh momentum.
Key CLPT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLPT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.63 | Sell | $17.71 | Sell |
| MA 10 | $18.13 | Sell | $17.69 | Sell |
| MA 20 | $17.08 | Buy | $16.93 | Buy |
| MA 50 | $14.11 | Buy | $14.92 | Buy |
| MA 100 | $12.46 | Buy | $13.86 | Buy |
| MA 200 | $14.86 | Buy | $13.63 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.15 | Neutral |
| Stoch RSI (14) | 1.25 | Buy |
| CCI (20) | 19.38 | Neutral |
| Williams %R (14) | -81.43 | Info |
| MACD (12,26,9) | -0.22 | Sell |
| ROC (12) | -5.56 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 18.57 | Buy |
| TRIX (15) | 1.43 | Buy |
| Awesome (5,34) | 2.36 | Buy |
| Ultimate (7,14,28) | 48.45 | Neutral |
| Momentum (10) | -0.46 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 17.29 | Buy |
| ADX (14) | 25.65 | Buy |
| ATR (14) | 0.62 | Info |
The 30-day technical picture shows a bullish tilt with RSI14 at 70. The price is above both the SMA50 ($12.38) and SMA200 ($14.43), suggesting constructive momentum relative to these moving averages. The stock has a defined near-term range and key levels: support at $11.13 and resistance at $18.53, with a 30-day range from $13.28 to $25.85.
Annualized volatility is high at 100%, underscoring notable price swings in the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.66 | $17.50 | $26.72 | 0% | Neutral | |
| $23.01 | $30.39 | $43.09 | +74% | Bullish | |
| $26.16 | $36.14 | $53.99 | +107% | Bullish | |
| $26.91 | $38.61 | $60.07 | +121% | Bullish | |
| $32.82 | $48.73 | $78.41 | +178% | Bullish | |
| $32.77 | $50.21 | $83.18 | +187% | Bullish | |
| $35.92 | $56.68 | $96.36 | +224% | Bullish | |
| $53.11 | $86.21 | $150.04 | +393% | Bullish | |
| $60.80 | $101.38 | $180.25 | +479% | Bullish | |
| $63.69 | $109.02 | $197.69 | +523% | Bullish | |
| $100.32 | $194.16 | $382.03 | +10.1x | Bullish | |
| $169.62 | $376.93 | $833.04 | +20.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $8.66 | $17.50 | $21.52 | +0.00% |
| August 2026 | $14.56 | $17.44 | $21.62 | -0.34% |
| September 2026 | $14.90 | $18.04 | $22.74 | +3.43% |
| October 2026 | $16.17 | $19.76 | $25.25 | +9.52% |
| November 2026 | $16.58 | $20.41 | $26.39 | +3.33% |
| December 2026 | $16.48 | $20.45 | $26.72 | +0.19% |
Click any year to see its month-by-month CLPT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CLPT could reach as high as $26.72, with a base case around $17.50 and support toward $8.66 — roughly 0% from $17.50. Price action looks broadly range-bound.
Expect CLPT to range from $23.01 to $43.09 through 2027. The $30.39 average target implies a +74% move from current prices. That is up +74% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CLPT price prediction for 2028 points to an average of $36.14 (low $26.16, high $53.99) — a potential gain of +107% on today's $17.50. Momentum favours further upside here.
In 2029, CLPT is projected to trade between $26.91 and $60.07, averaging $38.61 — a potential gain of +121% from today's $17.50. That is up +7% on the projected 2028 average. Buyers look set to stay in control over this stretch.
ClearPoint Neuro, Inc.'s 2030 outlook centres on $48.73, within a $32.82 to $78.41 range. That is up +26% on the projected 2029 average. That marks a +178% change versus current levels. Momentum favours further upside here.
By 2031, CLPT could reach as high as $83.18, with a base case around $50.21 and support toward $32.77 — roughly +187% from $17.50. Buyers look set to stay in control over this stretch.
Expect CLPT to range from $35.92 to $96.36 through 2032. The $56.68 average target implies a +224% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The CLPT price prediction for 2033 points to an average of $86.21 (low $53.11, high $150.04) — a potential gain of +393% on today's $17.50. Buyers look set to stay in control over this stretch.
In 2034, CLPT is projected to trade between $60.80 and $180.25, averaging $101.38 — a potential gain of +479% from today's $17.50. That is up +18% on the projected 2033 average. Momentum favours further upside here.
ClearPoint Neuro, Inc.'s 2035 outlook centres on $109.02, within a $63.69 to $197.69 range. That is up +8% on the projected 2034 average. That marks a +523% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CLPT could reach as high as $382.03, with a base case around $194.16 and support toward $100.32 — roughly +10.1x from $17.50. Momentum favours further upside here.
Expect CLPT to range from $169.62 to $833.04 through 2050. The $376.93 average target implies a +20.5x move from current prices. That is up +94% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLPT today (≈ 57.142857 CLPT) could be worth
$21,539.05
+$20,539.05 (+2054%) by 2050 · US Dollar
Based on the average projected CLPT price of $376.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLPTwould be worth at today's price.
$1,000 invested in CLPT on Jul 10, 2025 (≈ 83.61204 CLPT) would be worth
$1,463.21
+$463.21 (+46.3%) today · 1.46× · US Dollar
Based on a CLPT entry price of $11.96 vs. today's $17.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.72 | $934.83 | -6.5% |
| 1 month ago | $13.75 | $1,272.73 | +27.3% |
| 3 months ago | $8.68 | $2,016.13 | +101.6% |
| 6 months ago | $15.65 | $1,118.21 | +11.8% |
| 1 year ago | $11.96 | $1,463.21 | +46.3% |
| All time (5.0y) ago | $18.48 | $946.97 | -5.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLPT forecast.
Our base-case forecast reaches $35.00 around 2028.
Implied market cap at $35.00: $1.05B
The multi-year forecast depicts meaningful upside, with bullish sentiment prevailing from 2027 onward. In 2026 the avg price is $18.53 with 0% ROI and neutral sentiment, then rising to an avg of $34.54 in 2027 with 86.4% ROI and bullish sentiment, and $54.96 in 2030 with 196.6% ROI. The trajectory continues higher through 2035, 2040, and 2050, with 2033 avg $98.94 (434% ROI) and 2034 avg $111.34 (500.9% ROI), culminating in 2040 avg $208.37 (1024.5% ROI) and 2050 avg $414.81 (2138.6% ROI).
Across these years the sentiment remains bullish after 2026. These figures are estimates and not guarantees; forecast ranges (min/max) show substantial potential movement, reflecting uncertainty and risk.
Tap a question to reveal the answer.
In 2030 the forecast gives an avg price of $54.96 with a min of $34.65 and a max of $93.83, and a forecast ROI of 196.6% with a bullish sentiment.
Forecasts show bullish sentiment from 2027 onward, with average prices rising from $34.54 in 2027 to $414.81 in 2050 and ROIs reaching as high as 2138.6%. However, these are estimates, not guarantees, and risk factors and uncertainty remain.
Yes. The forecasted max prices include $184.62 in 2033 and $212.81 in 2034, with continued strength into 2035 and beyond, indicating the potential to exceed $100 in several years.
The 2040 forecast shows an avg price of $208.37, with a min of $93.77 and a max of $446.09.
$555.71M.
ClearPoint Neuro, Inc. Community Discussion
0Share your ClearPoint Neuro, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.